Literature DB >> 26850912

Cellular Ontogeny and Hierarchy Influence the Reprogramming Efficiency of Human B Cells into Induced Pluripotent Stem Cells.

Álvaro Muñoz-López1, Eddy H J van Roon2, Damià Romero-Moya1, Belén López-Millan1, Ronald W Stam2, Dolors Colomer3, Mahito Nakanishi4, Clara Bueno1, Pablo Menendez1,5.   

Abstract

Although B cells have been shown to be refractory to reprogramming into pluripotency, induced pluripotent stem cells (iPSCs) have been very recently generated, at very low efficiency, from human cord blood (CB)- and peripheral blood (PB)-derived CD19+CD20 + B cells using nonintegrative tetracistronic OSKM-expressing Sendai Virus (SeV). Here, we addressed whether cell ontogeny and hierarchy influence the reprogramming efficiency of the B-cell compartment. We demonstrate that human fetal liver (FL)-derived CD19 + B cells are 110-fold easier to reprogram into iPSCs than those from CB/PB. Similarly, FL-derived CD34+CD19 + B progenitors are reprogrammed much easier than mature B cells (0.46% vs. 0.11%). All FL B-cell iPSCs carry complete VDJH rearrangements while 55% and 45% of the FL B-progenitor iPSCs carry incomplete and complete VDJH rearrangements, respectively, reflecting the reprogramming of developmentally different B progenitors (pro-B vs. pre-B) within a continuous differentiation process. Finally, our data suggest that successful B-cell reprogramming relies on active cell proliferation, and it is MYC-dependent as identical nonintegrative polycistronic SeV lacking MYC (OSKL or OSKLN) fail to reprogram B cells. The ability to efficiently reprogram human fetal primary B cells and B precursors offers an unprecedented opportunity for studying developmental B-lymphopoiesis and modeling B-cell malignances.
© 2016 AlphaMed Press.

Entities:  

Keywords:  Fetal liver; Hierarchy; Human B cells; Human B-cell progenitors; Ig gene rearrangements; Induced pluripotent stem cells; OSKM; Ontogeny; Sendai virus

Mesh:

Substances:

Year:  2016        PMID: 26850912     DOI: 10.1002/stem.2303

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  9 in total

1.  Human acute leukemia induced pluripotent stem cells: a unique model for investigating disease development and pathogenesis.

Authors:  Clara Bueno; Pablo Menendez
Journal:  Stem Cell Investig       Date:  2017-06-13

2.  Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia.

Authors:  Diego Sánchez-Martínez; Matteo L Baroni; Francisco Gutierrez-Agüera; Heleia Roca-Ho; Oscar Blanch-Lombarte; Sara González-García; Montserrat Torrebadell; Jordi Junca; Manuel Ramírez-Orellana; Talía Velasco-Hernández; Clara Bueno; José Luís Fuster; Julia G Prado; Julien Calvo; Benjamin Uzan; Jan Cools; Mireia Camos; Françoise Pflumio; María Luisa Toribio; Pablo Menéndez
Journal:  Blood       Date:  2019-02-22       Impact factor: 22.113

3.  The Stagnant Adaptation of Defined and Xeno-Free Culture of iPSCs in Academia.

Authors:  Joseph T Vecchi; Tetsuro Wakatsuki
Journal:  Arch Stem Cell Res       Date:  2016-11-08

4.  Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector.

Authors:  Takashi Okumura; Yumi Horie; Chen-Yi Lai; Huan-Ting Lin; Hirofumi Shoda; Bunki Natsumoto; Keishi Fujio; Eri Kumaki; Tsubasa Okano; Shintaro Ono; Kay Tanita; Tomohiro Morio; Hirokazu Kanegane; Hisanori Hasegawa; Fumitaka Mizoguchi; Kimito Kawahata; Hitoshi Kohsaka; Hiroshi Moritake; Hiroyuki Nunoi; Hironori Waki; Shin-Ichi Tamaru; Takayoshi Sasako; Toshimasa Yamauchi; Takashi Kadowaki; Hiroyuki Tanaka; Sachiko Kitanaka; Ken Nishimura; Manami Ohtaka; Mahito Nakanishi; Makoto Otsu
Journal:  Stem Cell Res Ther       Date:  2019-06-24       Impact factor: 6.832

Review 5.  An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells.

Authors:  Arnab Ray; Jahnavy Madhukar Joshi; Pradeep Kumar Sundaravadivelu; Khyati Raina; Nibedita Lenka; Vishwas Kaveeshwar; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2021-06-07       Impact factor: 5.739

6.  Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency.

Authors:  Alvaro Muñoz-López; Damià Romero-Moya; Cristina Prieto; Verónica Ramos-Mejía; Antonio Agraz-Doblas; Ignacio Varela; Marcus Buschbeck; Anna Palau; Xonia Carvajal-Vergara; Alessandra Giorgetti; Anthony Ford; Majlinda Lako; Isabel Granada; Neus Ruiz-Xivillé; Sandra Rodríguez-Perales; Raul Torres-Ruíz; Ronald W Stam; Jose Luis Fuster; Mario F Fraga; Mahito Nakanishi; Gianni Cazzaniga; Michela Bardini; Isabel Cobo; Gustavo F Bayon; Agustin F Fernandez; Clara Bueno; Pablo Menendez
Journal:  Stem Cell Reports       Date:  2016-09-22       Impact factor: 7.765

7.  Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair.

Authors:  Julio Castaño; Ana B Herrero; Aldeheid Bursen; Federico González; Rolf Marschalek; Norma C Gutiérrez; Pablo Menendez
Journal:  Oncotarget       Date:  2016-05-24

8.  Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the "safe harbor" AAVS1 locus.

Authors:  Julio Castaño; Clara Bueno; Senda Jiménez-Delgado; Heleia Roca-Ho; Mario F Fraga; Agustín F Fernandez; Mahito Nakanishi; Raúl Torres-Ruiz; Sandra Rodríguez-Perales; Pablo Menéndez
Journal:  Stem Cell Res       Date:  2017-04-22       Impact factor: 2.020

9.  Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells.

Authors:  Paolo Petazzi; Raul Torres-Ruiz; Antonella Fidanza; Heleia Roca-Ho; Francisco Gutierrez-Agüera; Julio Castaño; Sandra Rodriguez-Perales; Rafael Díaz de la Guardia; Belén López-Millán; Anna Bigas; Lesley M Forrester; Clara Bueno; Pablo Menéndez
Journal:  Mol Ther Nucleic Acids       Date:  2020-02-27       Impact factor: 8.886

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.